Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Romark Laboratories L.c.
Romark Laboratories L.c.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Alinia
Nitazoxanide
2004-07-21
Diarrhea
,
Giardiasis
,
Cryptosporidiosis
,
Protozoan infections
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Nitazoxanide
hepatitis b
,
chronic hepatitis b
,
gastroenteritis
,
clostridioides difficile
,
colitis
,
crohn disease
,
hepatitis
,
hepatitis a
,
hepatitis c
,
chronic hepatitis c
,
chronic hepatitis
,
covid-19
,
human influenza
,
enterovirus
,
rhinovirus
,
enterovirus infections
,
rotavirus infections
,
diarrhea
,
clostridium infections
,
amebiasis
,
amebic dysentery
,
hiv infections
,
cryptosporidiosis
,
infections
,
communicable diseases
,
adenoviridae infections
,
caliciviridae infections
Benzocaine
renal insufficiency
,
lymphoma
,
t-cell lymphoma
,
immunoblastic lymphadenopathy
,
enteropathy-associated t-cell lymphoma
,
t-cell lymphoma peripheral
,
intestinal diseases
,
heart diseases
,
neuroendocrine tumors
,
carcinoid tumor
,
malignant carcinoid syndrome
,
carcinoid heart disease
,
serotonin syndrome
Tenofovir
heart disease risk factors
,
metabolic diseases
,
lipid metabolism disorders
,
healthy volunteers/patients
,
renal insufficiency
,
viremia
,
biliary liver cirrhosis
,
cholangitis
,
tuberculosis
,
hiv-1
,
hiv-2
,
breast feeding
,
pregnancy
,
antibiotic prophylaxis
,
virus diseases
,
obesity
,
metabolic syndrome
,
body weight changes
,
fasting
,
hiv infections
,
hiv
,
acquired immunodeficiency syndrome
,
infections
,
communicable diseases
,
immunologic deficiency syndromes
,
hepatitis b
,
hepatitis
,
hepatitis a
,
body weight
,
chronic hepatitis b
,
persistent infection
,
weight gain
,
sarcoma
,
kaposi sarcoma
,
immunosuppression therapy
,
cardiovascular diseases
,
chronic hepatitis
,
metabolic bone diseases
,
osteoporosis
,
hepatitis c
,
coinfection
,
chemical and drug induced liver injury
,
proteinuria
,
hiv seropositivity
,
aging
Alfacalcidol
psoriasis
,
chronic obstructive pulmonary disease
,
drug interactions
,
bacterial infections
,
alopecia
,
depressive disorder
,
neoplasms
,
hypertension
,
respiratory tract infections
,
infections
,
chronic renal insufficiency
,
kidney diseases
,
aspergillosis
,
anemia
,
allergic bronchopulmonary aspergillosis
,
abdominal obesity
,
onychomycosis
,
prostatic hyperplasia
,
hyperplasia
,
prostatic neoplasms
,
hypogonadism
Albinterferon alfa-2b
hepatitis c
,
chronic hepatitis c
,
hepatitis
,
chronic hepatitis
,
hepatitis a
Nepidermin
non-small-cell lung carcinoma
,
lung neoplasms
,
exanthema
,
breast neoplasms
Retinol
lung diseases
,
mycobacterium avium complex
,
bronchiectasis
,
mycobacterium avium-intracellulare infection
,
mycobacterium infections
Fendrix
meningococcal infections
,
malaria
,
streptococcal infections
,
pneumonia
,
papillomavirus infections
,
herpesviridae infections
,
meningitis
,
otitis media
,
otitis
,
virus diseases
,
pneumococcal pneumonia
,
streptococcus pneumoniae
,
meningococcal meningitis
,
infections
,
hiv
,
papillomavirus vaccines
,
hematopoietic stem cell transplantation
,
hepatitis b
,
hepatitis
,
hepatitis a
,
chronic hepatitis b
,
chronic hepatitis
,
diphtheria
,
tetanus
,
haemophilus influenzae type b
,
whooping cough
,
poliomyelitis
,
human influenza
,
tetany
,
fibrosis
,
diabetes mellitus
,
rotavirus infections
,
liver cirrhosis
,
type 2 diabetes mellitus
,
healthy volunteers/patients
,
liver diseases
,
gastrointestinal diseases
,
digestive system diseases
,
viral hepatitis human
,
dna virus infections
Fluzone
h7n9 subtype influenza a virus
,
respiratory syncytial virus infections
,
influenza in birds
,
herpes zoster
,
tetanus
,
diphtheria
,
herpes simplex
,
hepatitis b
,
whooping cough
,
hepatitis
,
poliomyelitis
,
meningococcal infections
,
human influenza
,
h1n1 subtype influenza a virus
,
haemophilus influenzae type b
,
infections
,
common cold
,
healthy volunteers/patients
,
hiv infections
,
influenza a virus
Flumist
pneumonia
,
chronic obstructive pulmonary disease
,
pneumococcal pneumonia
,
haemophilus influenzae
,
streptococcus pneumoniae
,
virus diseases
,
respiratory tract diseases
,
respiration disorders
,
arthralgia
,
neisseria meningitidis
,
dengue
,
influenza in birds
,
h5n1 subtype influenza a virus
,
chronic disease
,
disease
,
orthomyxoviridae
,
fever
,
humans
,
meningitis
,
meningococcal infections
,
human influenza
,
h1n1 subtype influenza a virus
,
multiple sclerosis
,
relapsing-remitting multiple sclerosis
,
sclerosis
,
pneumococcal infections
,
haemophilus infections
,
otitis media
,
respiratory tract infections
,
communicable diseases
,
disease progression
,
sinusitis
,
asthma
,
bronchitis
,
bronchial spasm
,
narcolepsy
,
myositis
,
infectious encephalitis
,
immunologic tests
,
malaria
,
otitis
,
emergencies
,
drug-related side effects and adverse reactions
Flucelvax
h7n9 subtype influenza a virus
,
influenza in birds
,
h5n1 subtype influenza a virus
,
chronic disease
,
disease
,
orthomyxoviridae
,
fever
,
humans
,
meningitis
,
meningococcal infections
,
human influenza
,
h1n1 subtype influenza a virus
,
multiple sclerosis
,
relapsing-remitting multiple sclerosis
,
sclerosis
,
pneumococcal infections
,
haemophilus infections
,
influenza a virus
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use